Is Colgate-Palmolive Quietly Building The Next Pet Food Empire?
Colgate-Palmolive’s premium strategy and pet nutrition expansion drive growth, with a $115 target signaling 26% upside. Read more about CL stock here.
IPO Watch: Allchem Lifescience files draft papers with SEBI to raise ₹190 crore via fresh issue; Check details
Allchem Lifescience has filed its DRHP with SEBI for an IPO. Established in 2017, it specializes in active pharmaceutical ...